ACTA MEDICA MEDITERRANEA, vol.30, no.2, pp.465-471, 2014 (SCI-Expanded)
Background: Several clinical studies have shown the effect of mefformine on survival in pancreatic cancer. We aimed to evaluate whether the use of mefformin in diabetic pancreatic cancer patients provides a survival advantage or not.